File:PMC4186578 OL-08-05-1912-g00.png

License

Attribution 3.0 Unported (CC BY 3.0)

Summary

Author:Mohr M, Schliemann C, Biermann C, Schmidt LH, Kessler T, Schmidt J, Wiebe K, Müller KM, Hoffmann TK, Groll AH, Werner C, Kessler C, Wiewrodt R, Rudack C, Berdel WE ,Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster (Openi/National Library of Medicine) Source:https://openi.nlm.nih.gov/detailedresult?img=PMC4186578_OL-08-05-1912-g00&query=Laryngeal%20papillomatosis&it=xg&req=4&npos=62 Description:f1-ol-08-05-1912: Representative bronchoscopic images of the laryngeal (first row) and tracheal (second row) papilloma manifestations in Patient 1. Images in the first column demonstrate the pre-therapeutic condition. On day three, following the first dose of bevacizumab, a significant regression of papilloma lesions was observed (second column) and a very good partial remission with only minimal papilloma residues was documented under continuous bevacizumab treatment on day 139 (third column).